TYSABRIActive Ingredient(s): Natalizumab
FDA Approved: * November 23, 2004
Pharm Company: * BIOGEN IDEC
Category: Multiple Sclerosis
Natalizumab, sold under the brand name Tysabri among others, is a medication used to treat multiple sclerosis and Crohn's disease. It is a humanized monoclonal antibody against the cell adhesion molecule α4-integrin. It is given by intravenous infusion every 28 days. The drug is believed to work by reducing the ability of inflammatory immune cells to attach to and pass through the cell layers lining the intestines and blood–b... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.
I have MS and infuse with Tysabri. I am having severe muscle spasms. I am allergic to Lyrica, Baclofen, Methocarbamol, a...1 REPLY
I take Tysabri for multiple sclerosis. I am struggling with arthritis pain, as I can't take immuno suppresant therap...3 REPLIES
tysabri infomation obout side afects and interaction with other drugs...